TerminatedNCT01465074
Official study titleEffects of Acute Nicotine on Long-term Potentiation in the Dorsolateral Prefrontal Cortex of Patients With Schizophrenia and Healthy Controls
This study ended early.
In TorontoSchizophreniaMedication studyAges 18–55
- Countries
- Canada
- Sponsor
- Centre for Addiction and Mental Health (Hospital / academic medical center)
CompletedNCT01222793
This study has finished and is no longer accepting participants.
In BaltimoreSchizophreniaObservational studyAges 18–45
- Countries
- United States
- Sponsor
- National Institute on Drug Abuse (NIDA)
CompletedNCT00552500
About this title
Effects of Atypical Antipsychotic and Valproate Combination Therapy on Glucose and Lipid Metabolism in Schizophrenia
Read the official source — NCT00552500Official study titleEffects of Atypical Antipsychotic and Valproate Combination Therapy on Glucose and Lipid Metabolism in Schizophrenia
This study has finished and is no longer accepting participants.
In St LouisSchizophreniaMedication studyAges 18–60
- Countries
- United States
- Sponsor
- Washington University School of Medicine
CompletedNCT06906224
Official study titleEffects of Different Doses of Buspirone Combined With Clozapine on Psychiatric Symptoms and Cognitive Function in Patients With Schizophrenia: A Randomised, Double-blind, Placebo-controlled Trial
This study has finished and is no longer accepting participants.
In WuhuSchizophreniaMedication studyAges 1–65
- Countries
- China
- Sponsor
- Chuanfu Song
CompletedNCT01376076
Official study titleEvaluation of the Effects of Sequential Multiple-Dose Regimens of Cariprazine on Cardiac Repolarization in Patients With Schizophrenia
This study has finished and is no longer accepting participants.
Multiple locations, including GlendaleSchizophreniaMedication studyAges 18–50
- Countries
- United States
- Sponsor
- Forest Laboratories
CompletedNCT01318850
Official study titleAnalysis of the Effects of Cognitive Remediation Therapy on Schizophrenia Patients Through fMRI Techniques
This study has finished and is no longer accepting participants.
In BarcelonaSchizophreniaBehavioural studyAges 18+
- Countries
- Spain
- Sponsor
- Hospital Clinic of Barcelona
CompletedNCT01266174
What is this study about?Researchers compared Eltoprazine and placebo to find out how the approaches affected memory, attention and other thinking skills in adults with schizophrenia.
This study has finished and is no longer accepting participants.
Multiple locations, including Los AngelesSchizophreniaMedication studyAges 18–65
- Countries
- United States
- Sponsor
- Amarantus BioScience Holdings, Inc.
CompletedNCT01641900
Official study titleSleep-dependent Memory Processing in Schizophrenia
This study has finished and is no longer accepting participants.
In BostonSchizophreniaMedication studyAges 18–45
- Countries
- United States
- Sponsor
- Massachusetts General Hospital (Hospital / academic medical center)
CompletedNCT01614093
This study has finished and is no longer accepting participants.
In CatonsvilleSchizophreniaMedication studyAges 18–54
- Countries
- United States
- Sponsor
- University of Maryland, Baltimore
CompletedNCT01140620
Official study titleEffects of NMDA Receptor Antagonism on Cognitive Processes in Healthy Volunteers and Its Reversal by a Dopamine Antagonist: Comparison to Patients With Schizophrenia
This study has finished and is no longer accepting participants.
Multiple locations, including LondonSchizophreniaMedication studyAges 18–45
- Countries
- United Kingdom
- Sponsor
- University of Manchester
CompletedNCT03967431
Official study titleEffects of Narrative Enhancement and Cognitive Therapy (NECT) on Self-stigma in Patients With Schizophrenia: A Randomized Controlled Study
This study has finished and is no longer accepting participants.
In TaipeiSchizophreniaInterventional studyAges 20–64
- Countries
- Taiwan
- Sponsor
- National Yang Ming Chiao Tung University
CompletedNCT03662425
Official study titleEffects of Oxytocin on Negative Symptoms and Social Cognition in Schizophrenia and Its Behavioral Mechanisms
This study has finished and is no longer accepting participants.
In ShanghaiSchizophreniaMedication studyAges 18–55
- Countries
- China
- Sponsor
- Shanghai Mental Health Center